NFJ Investment Group LLC Has $40.43 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• NFJ Investment Group LLC reduced its holdings in UnitedHealth Group by 18.5%, owning 77,183 shares worth approximately $40.43 million at the end of the first quarter.
• UnitedHealth Group reported its quarterly earnings with $4.08 EPS, missing estimates of $4.45 EPS, while the revenue grew by 12.9% year-over-year.
• The company is set to pay a quarterly dividend of $2.21 per share, which reflects an annualized yield of 2.9%.

NFJ Investment Group LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 77,183 shares of the healthcare conglomerate's stock after selling 17,546 shares during the quarter. UnitedHealth Group comprises about 1.4% of NFJ Investment Group LLC's investment portfolio, making the stock its 18th largest holding. NFJ Investment Group LLC's holdings in UnitedHealth Group were worth $40,425,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the period. Algert Global LLC raised its holdings in UnitedHealth Group by 5.3% in the 4th quarter. Algert Global LLC now owns 3,175 shares of the healthcare conglomerate's stock valued at $1,606,000 after buying an additional 160 shares during the period. CoreCap Advisors LLC grew its position in UnitedHealth Group by 127.5% in the 4th quarter. CoreCap Advisors LLC now owns 3,553 shares of the healthcare conglomerate's stock valued at $1,797,000 after acquiring an additional 1,991 shares in the last quarter. Finally, Deprince Race & Zollo Inc. grew its position in UnitedHealth Group by 6.3% in the 4th quarter. Deprince Race & Zollo Inc. now owns 81,222 shares of the healthcare conglomerate's stock valued at $41,087,000 after acquiring an additional 4,817 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Bank of America boosted their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Wolfe Research lowered their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Truist Financial reduced their price objective on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research note on Wednesday, July 16th. Finally, Cantor Fitzgerald restated an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $354.86.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 1.6%

Shares of UnitedHealth Group stock traded up $5.07 during trading hours on Monday, reaching $320.46. The stock had a trading volume of 18,394,073 shares, compared to its average volume of 12,810,354. The firm has a market capitalization of $290.23 billion, a price-to-earnings ratio of 13.88, a P/E/G ratio of 2.04 and a beta of 0.44. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a 50 day simple moving average of $288.78 and a two-hundred day simple moving average of $372.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.